# Rob Carlson

> Rob Carlson is a Series A investor at Biodesic (Frederick) backing Biotechnology and Genetics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Biodesic](https://shizune.co/investors/profile/biodesic)
- Location: Frederick, United States
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/rob-carlson-22a9792
- X (Twitter): https://twitter.com/rob_carlson
- Website: https://x.com/rob_carlson

Rob Carlson is a Series A investor at Biodesic in Frederick focused on Biotechnology and Genetics. Rob is interested in the future role of biology as a human technology and is a founder of Biodesic, a consulting firm at the juncture of biology and other disciplines such as marketing, engineering, and investment. He has worked to develop new biological technologies in both academic and commercial environments, focusing on molecular measurementand microfluidic systems. Carlson is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Genetics | 1 | 33% |
| Life Science | 1 | 33% |
| Bioinformatics | 1 | 33% |
| Environmental Consulting | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Series B | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ZymeCO | ZymeCO is a bio-manufacturing company that develops enzyme-based biological products designed for sustainable agriculture and turf management. The company utilizes a bio-process that transforms organic matter to build soil health, accelerate residue decomposition, and boost plant growth. | $4M | Series A | Jul 01, 2026 |  |
| Parse Biosciences | Parse Bio is a biotechnology startup company developing single-cell sequencing kit solutions for researchers.By using combinatorial cDNA barcoding within cells themselves, Parse Biosciences’s technology allows researchers to eliminate the need for complex and expensive microfluidic instruments. Additionally, the company’s technology enablessamples to be fixed, frozen, and stored, allowing researchers to separate out the sample extraction from downstream library preparation steps. This capability empowers researchers to run fixed samples collected on different dates together in a single experiment, providing greater control over sample handling and reducing handling errors. Split Biosciences rebranded as Parse Biosciences in 2020.The Seattle, Washington-based biotech company was established in 2018 by Alex Rosenberg, Charlie Roco, and Georg Friedrich Seelig. | $41.5M | Series B | Feb 15, 2022 |  |
| Parse Biosciences | Parse Bio is a biotechnology startup company developing single-cell sequencing kit solutions for researchers.By using combinatorial cDNA barcoding within cells themselves, Parse Biosciences’s technology allows researchers to eliminate the need for complex and expensive microfluidic instruments. Additionally, the company’s technology enablessamples to be fixed, frozen, and stored, allowing researchers to separate out the sample extraction from downstream library preparation steps. This capability empowers researchers to run fixed samples collected on different dates together in a single experiment, providing greater control over sample handling and reducing handling errors. Split Biosciences rebranded as Parse Biosciences in 2020.The Seattle, Washington-based biotech company was established in 2018 by Alex Rosenberg, Charlie Roco, and Georg Friedrich Seelig. | $7M | Series A | Jan 26, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Ag Startup Engine](https://shizune.co/investors/profile/ag-startup-engine) — VC Fund, 1 deal together
- [Janus Henderson Investors](https://shizune.co/investors/profile/janus-henderson-investors) — VC Fund, 1 deal together
- [Logos Capital](https://shizune.co/investors/profile/logos-capital) — VC Fund, 1 deal together
- [Marshall Wace](https://shizune.co/investors/profile/marshall-wace) — VC Fund, 1 deal together
- [Old Tom Capital](https://shizune.co/investors/profile/old-tom-capital) — VC Fund, 1 deal together
- [Sahsen Ventures](https://shizune.co/investors/profile/sahsen-ventures) — VC Fund, 1 deal together

## About Biodesic

VC Fund



2 contacts available at Biodesic.

| Name | Title | Profile |
| --- | --- | --- |
| Rob Carlson | Founder | https://shizune.co/investors/profile/rob-carlson |
| Rik Wehbring | Principal | https://shizune.co/investors/profile/rik-wehbring |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Rob Carlson invest in?

Rob Carlson invests primarily in Biotechnology, Genetics and Life Science startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rob Carlson last invest?

The most recent investment recorded for Rob Carlson closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co